Dupilumab prevents nasal epithelial function alteration by IL‐4 in vitro: Evidence for its efficacy

Abstract

Dupilumab, in vitro, restored epithelial integrity by counteracting the effect of IL-4 on the epithelial barrier (increased epithelial permeability, decreased ciliary beating efficiency, and decreased wound repair rate).